The use of skin-adherent devices among patients with diabetes is on the rise. This multicenter French cross-sectional study evaluated the prevalence and consequences of skin reactions among 851 adult diabetic patients who used glucose sensors or insulin pumps in the last decade. Results showed that 28% of sensor users and 29% of pump users had skin reactions, occurring more frequently among women and patients with a history of eczema. Symptoms suggested skin irritation rather than an allergy. Skin reactions occurred within the first 24 hours in 22–24% of cases and after more than 6 months in 38% and 47% of cases for sensors and pumps, respectively. Finally, 12% of patients with a reaction to sensors and 7% of patients with a reaction to pumps discontinued using the device.
- Continuous blood glucose monitoring
- Insulin pump
- Skin reaction
- Subcutaneous insulin infusion